Protoporphyria is a rare inherited disorder that results from a defect in hemoglobin synthesis. The disorder is caused by a deficiency of specific enzymes involved in the biosynthesis of porphyrins, which are essential precursors to hemoglobin. Protoporphyria is characterized by an accumulation of porphyrins, particularly protoporphyrin IX, in the body, which can cause a variety of clinical manifestations, including photosensitivity, anemia, and skin problems. The disease has several forms, the most well-known of which are typical protoporphyria and erythropoietic protoporphyria. Symptoms vary depending on the form of the disease and may include acute abdominal pain, liver dysfunction, and other systemic manifestations.
History of the disease and interesting historical facts
Protoporphyria was first described in the late 19th century, but already in the early years of studying blood diseases, cases comparable to protoporphyria were identified. At that time, the disease was perceived as a rare affliction about which there was insufficient information. In the 1960s, active research began, during which the genetic basis of the disease was established. Interesting fact: during the clinical study of protoporphyria, it was found that some patients could have hypersensitivity to sunlight, which largely determined the first clinical observations. There is also evidence that some historical figures had symptoms similar to protoporphyria, although this cannot be said with certainty, since diagnostics were not available at that time.
Epidemiology
Protoporphyria is a rare disease with an average prevalence of 1 in 100,000 to 1 in 200,000 people in high-population countries. The disease is most common in people of Northern European descent, with lower prevalence in African and Asian populations. It is known that in conditions of high insolation, the symptoms of protoporphyria can manifest themselves much more clearly. As a rule, the disease is hereditary, with the probability of transmission from affected parents being about 25% in the presence of a recessive gene.
Genetic predisposition to this disease
Protoporphyria is caused by mutations in genes responsible for the synthesis of enzymes involved in the metabolism of porphyrins. The main gene associated with the development of this disease is the FECH gene, located on chromosome 18. Mutations in this gene lead to a deficiency of the enzyme responsible for the final stage of hemoglobin synthesis. As a rule, these mutations are recessive, and two defective alleles are required for the manifestation of the disease. Mutations in genes responsible for the activity of other enzymes in the synthesis pathway are also found. Genetic counseling is recommended for all members of families where cases of the disease have been registered in order to assess the risk and identify carriers of mutant alleles.
Risk factors for the development of this disease
The main risk factors for protoporphyria include:
- Genetic predisposition – a family history of protoporphyria;
- Environmental factors – solar radiation, which can provoke an exacerbation of the condition;
- Psycho-emotional stress – some studies show a link between stress and exacerbations of symptoms;
- Certain medications - some medications can make your condition worse if you have a predisposition to the disease;
- The presence of concomitant diseases, such as hepatitis, which can worsen the clinical picture of protoporphyria.
Diagnosis of this disease
Diagnosis of protoporphyria includes several stages and methods:
- Main symptoms: Patients experience photosensitivity, swelling and inflammation of the skin, anemia, abdominal pain and liver dysfunction.
- Laboratory tests: Analysis of porphyrin levels in serum, urine and faeces is the most important diagnostic method. Protoporphyrin levels may be significantly elevated.
- Radiological examinations: Ultrasound and magnetic resonance imaging may be useful in assessing the condition of the liver and other organs.
- Other types of diagnostics: Genetic testing to determine mutant alleles and genetic counseling.
- Differential diagnosis: It is important to conduct a differential diagnosis with other forms of porphyria, dermatological diseases and hepatitis.
Treatment
Treatment of protoporphyria involves a comprehensive approach taking into account the individual characteristics of the patient:
- General treatment: Reduce time spent in the sun, use protective creams and clothing to prevent photodermatitis.
- Pharmacological treatment: Use of beta-carotene, which can reduce skin sensitivity. Also prescribed are drugs that improve liver function.
- Surgical treatment: In particularly severe cases, surgery, including a liver transplant, may be considered.
- Other types of treatment: Phototherapy and the use of new technologies such as gene therapy are being actively researched but are still in the development stage.
List of medications used to treat this disease
- Beta-carotene;
- Zolulin;
- Indomethacin;
- Metronidazole;
- Drugs that improve liver function (eg, essential phospholipids).
Disease monitoring
Monitoring of protoporphyria includes regular follow-up examinations to assess the patient's condition:
- Control stages: Regular testing of porphyrin levels, liver function tests, and complete blood counts are necessary.
- Forecast: Early diagnosis and treatment can significantly improve quality of life and reduce the number of exacerbations.
- Complications: Improper management of the disease can lead to serious complications, including liver failure, metabolic disorders, and other systemic disturbances.
Age-related features of the disease
Protoporphyria can manifest itself at any age, but the age at which clinical symptoms begin to develop varies:
- In infants and young children, symptoms may be vague and misinterpreted as dermatological or infectious diseases;
- In adolescents, symptoms may be more severe due to hormonal changes;
- In older people, protoporphyria can be combined with other diseases, which complicates diagnosis.
Questions and Answers
- What are the main symptoms of protoporphyria? The main symptoms are photosensitivity, abdominal pain, anemia, dermatological disorders.
- How is protoporphyria diagnosed? Diagnosis includes laboratory tests for porphyrin levels, genetic tests, and clinical assessment.
- What treatment is recommended for protoporphyria? Treatment includes drug therapy, lifestyle changes, and in severe cases, surgery.
- What is the prevention of exacerbations of protoporphyria? Prevention is based on avoiding sunlight, following a regimen and monitoring the condition of the liver.
- Does age affect the course of protoporphyria? Yes, age can influence the presentation of symptoms and associated medical conditions, which is important to consider when treating.
